Screener
Silexion Therapeutics SLXN Q3 2025 earnings
Reported November 12, 2025 · Before market open
EPS-$2.88Beat by $0.52
EPS estimate-$3.40
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$9.10
Versus estimates
Diluted EPS
FAQ
- When did Silexion Therapeutics report Q3 2025 earnings?
- Silexion Therapeutics (SLXN) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were Silexion Therapeutics's Q3 2025 revenue and EPS?
- Silexion Therapeutics reported eps of $-2.88 for Q3 2025.
- Did Silexion Therapeutics beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-3.40 by $0.52.
- How did Silexion Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 84.2% from $-18.27.
- Where can I find Silexion Therapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001178913-25-003756) and the 10-Q periodic report (0001178913-25-003753) directly on SEC EDGAR. The filing index links above go to sec.gov.
